Protein Supplementation4BettProNCT05228236
Plant Based Protein and Whey Protein: Effects on Body Composition and Performance
A study testing Plant based protein and Whey protein in people with Protein Supplementation, run by Bettery S.A. at 1 site in Portugal.
Trial summary
This study aimed to investigate the effects of a newly developed plant-based protein blend regarding health and safety, body composition, and performance on healthy and physically active adult individuals, specifically team sports athletes. Read more about this study
- Who is it for?
- Ages 18 to 35 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Protein Supplementation
- What is being tested?
- Plant based protein and Whey protein
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 sitePortugal
- Study dates
- 1 Sep 2021to 10 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Subjects currently engaged in a Futsal training program in a competition team, currently engaged in practice for at least 1 year and at least 3 times per week.
Who cannot join
- Individuals taking any type of drug (including anabolic steroids), medicines or supplements that may enhance body composition or performance, 3 months prior to the beginning of the trial.
- Clinical diagnose of a disease that might compromise tolerance to the supplements or influence body composition or performance.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparing the Effects of Plant Based Protein vs. Whey Protein on Performance and Body Composition of Futsal Players
This study aimed to investigate the effects of a newly developed plant-based protein blend regarding health and safety, body composition, and performance on healthy and physically active adult individuals, specifically team sports athletes. A randomized, double-blind, controlled trial was used to compare the effects of the plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition, biochemical markers, muscle strength and power, as well as aerobic performance in male futsal players. The working hypothesis is that this special blend of plant-based protein will be equivalent to whey protein, not only regarding body composition and performance, but also insofar as health and safety at the biochemical and physiological level.
Read the detailed description
A randomized, double-blind, controlled trial was performed to investigate health and safety following supplementation with a newly developed plant-based protein blend and to compare the effects of this plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition and performance. Prior to intervention, volunteers' general health and ability to participate in the study were assessed. The study involved 50 male futsal players currently engaged in a training program and competing. Before engaging the 8-week supplementation protocol, participants underwent measurements of body composition, strength and power, and aerobic performance, as well as a full profile of biochemical health markers, and assessment of food and fluid intake. Evaluations were repeated after 4 weeks, for follow up and to detect potential compliance issues, and after 8 weeks of supplementation. Assessments took place in the morning (starting at 7:00 a.m.) after an overnight fast, except for the performance tests, which were performed following consumption of a standard, meal replacement bar.
Anthropometry and Body Composition - Wearing minimal clothing and no shoes, participants had their weight and height measured on a scale and stadiometer (Seca, Hamburg, Germany), respectively. Body composition, namely bone mineral content, fat mass and fat free mass, were evaluated by dual energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic, Waltham, USA) and skeletal muscle through the evaluation of the muscle thickness of the rectus femoris by ultrasonography (model WED-180 HL, Shenzhen,China). Total body water and its intra and extracellular compartments were estimated from whole body resistance (R) and reactance (Xc), measured through bioelectrical impedance analysis (BIA), using a single frequency device of 50 kHz (BIA-101, RJL/Akern Systems, Firenze, Italy). From the raw R and Xc data, the phase angle was additionally determined, using the Akern Software.
Muscle Strength and Power, and Aerobic Performance - Strength was assessed using the handgrip strength test, as well as the back squat and bench press 1 repetition maximum (1 RM). The handgrip strength test was used to evaluate the maximal isometric force of the muscles of the hand and forearm. Using a portable hand dynamometer (JAMAR, Sammons Preston, Bolingbrook, IL, USA), participants were assessed for both hands alternately, in a stand-up position. The maximal force generated out of 3 attempts was considered for analysis. Additionally, muscle strength was evaluated by 1RM back squat and bench press in a Multipower machine, using a velocity-based training device (Vitruve Encoder, Madrid, Spain). Muscle power was assessed during maximal cycling (Wingate test) and jumping movements. During the Wingate test, participants were instructed to cycle (Monark 894 Peak Bike, Vansbro, Sweden) against a predetermined resistance (7.5% body weight), as fast as possible, for 30 seconds. Vertical jumps, namely the squat jump, countermovement jumps using both legs and single legs, as well as the Abalakov countermovement jump, were performed on a multicomponent force platform (Chronojump Boscosystem, Barcelona, Spain) interfaced with a computer. The best out of 3 attempts was also considered for analysis of this methodology. Aerobic performance was assessed by VO2peak and maximal aerobic speed (MAS), determined using a breath-by-breath gas analyzer (Quark, Cosmed, Italy) in an incremental test performed on a treadmill (Axelero, MEDEN-INMED, Koszalin, Poland). After 3 minutes of warm-up at 5 km/h, participants began the test at 6 km/h and 2% inclination. Each minute, the speed increased 1 km/h until volitional exhaustion. The VO2peak was considered the highest 30 sec average value of VO2 and MAS, the speed at the last completed stage.
All tasks were performed by the participants with direct supervision of sport scientists and/or exercise physiologists, with prior knowledge of the methodologies, and experience handling the equipments and corresponding softwares.
Biochemical Markers - For biochemical health markers, saliva and whole blood, in EDTA tubes, were collected per the standard protocols. . From whole blood, plasma was separated when necessary. Blood measurements included hematocrit, glucose, C-reactive protein (CRP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), and creatinine, using spectrophotometry techniques in an automated equipment (Vario Photometer II DP310, Diglobal Gmbh, Berlin, Germany). Saliva was collected for cortisol evaluation in Enzyme-Linked Immunosorbent Assay (ELISA) commercial kits (Salimetrics, PA, USA).
Nutritional Assessment - Following extensive verbal and written instructions, diet control and food patterns were characterized using 3-day food records (2 non-consecutive weekdays and 1 weekend day). Participants were instructed to maintain their dietary pattern for the 8 weeks of the study. Energy, macronutrient, and micronutrient intake were quantified using a dietary analysis software (Nutritics Research Edition (v5.09), Dublin, Ireland).
Randomization and Supplementation - Eligible participants were assigned to one of the two arms of the study using a covariate adaptive randomization procedure considering the covariates age, handgrip strength, whole body fat-free mass, and whole-body fat mass percentage. The investigator responsible for the sample randomization and supplements distribution was not directly involved in participants' eligibility interview or data collection. The supplementation protocol was similar for both the plant-based and whey protein, with the uptake of a single dose of ~30 g occurring 30-60 min after physical practice on training days or 30-60 min before bedtime on rest days. Supplementation compliance was assessed by questionnaire at the end of weeks 4 and 8.
Sample Size Justification - Previous, similar studies showed no differences between the abovementioned supplements regarding the analyzed variables of interest. In cases where there are no differences between the arms of the study, an effect size does not exist, so a power analysis is not a valid approach. As our hypothesis is that there will be no difference between the newly developed plant-based protein blend and whey protein, we can consider a non-inferiority trial and, therefore, our sample size can be similar to that of previous studies. Additionally, despite the time course of muscle hypertrophy not being exactly known, an 8-week intervention would be considered the minimum timeline for true hypertrophy to be detectable/measurable after 6-8 weeks of resistance training (using medical imageology i.e., ultrasound). Furthermore, it has been reported that to detect hypertrophy differences following supplementation with proteins of different quality, the number of subjects needed should be in the range of at least 25 per group. We have chosen to go with a robust approach. Therefore, our proposed sample size is of 25 participants per group.
Statistics - All statistical analyses are being carried out using IBM SPSS Statistics (Version 25.0, NY, IBM). Basic descriptive data were run to characterize the study participants. All variables were checked for normality, using Kolmogorov-Smirnov test. Participants were assigned to either a plant-based protein (n = 25) or animal protein group (n = 25), based on handgrip strength, age, fat mass or fat-free mass using a stratified random assignment. Independent Sample T tests will be applied to compare means between supplementation groups, at baseline. Time and time-by-group interactions will be evaluated by repeated-measures ANOVA. The equality of the matrix of variance and sphericity will be explored with the Levene F test and Mauchly's test, respectively. Overall significance level for α will be set at p ≤ 0.05.
- Conditions
- Protein Supplementation
- Being tested
- Plant based protein, Whey protein
- Keywords
- Plant-based Protein, Body composition, Physical Performance, Biochemical Health Markers, Supplementation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Plant based proteinDietary supplement
A single dose of ~30 g of a plant-based protein blend was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days.
Whey proteinDietary supplement
A single dose of ~30 g of whey protein was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days.
| Study group | Role | What they receive |
|---|---|---|
| Plant based protein | Experimental | Not described Receives: Dietary Supplement: Plant based protein |
| Whey Protein | Experimental | Not described Receives: Dietary Supplement: Whey protein |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body composition parameter - change in fat free mass (FFM)
FFM (kg) was assessed by dual energy X-ray absorptiometry
Measured: Baseline, week 4 and week 8
Body composition parameter - change in fat mass (FM)
FM (%) was assessed by dual energy X-ray absorptiometry
Measured: Baseline, week 4 and week 8
Body composition parameter - change in muscle thickness
muscle thickness of the rectus femoris (mm) was assessed by ultrasonography
Measured: Baseline, week 4 and week 8
Body composition parameter - change in body water
total body water, intracellular water and extracellular water (L) were assessed by bioelectrical impedance analysis
Measured: Baseline, week 4 and week 8
Performance parameter - change in strength
Maximal isometric forearm strength (N) was assessed using a handgrip dynamometer
Measured: Baseline, week 4 and week 8
Performance parameter - change in maximum strength
Maximum strength (kg) was predicted from 1-RM in back squat and bench press exercises using a Multipower machine withVitruve technology
Measured: Baseline, week 4 and week 8
Performance parameter - change in peak power
Muscle power (Watt) was assessed with a supramaximal cycling test on cycle ergometer
Measured: Baseline, week 4 and week 8
Performance parameter - change in jump height
Vertical jump height (cm) was assessed on a multicomponent force platform interfaced with the Chronojump software
Measured: Baseline, week 4 and week 8
Aerobic performance - change in Oxygen uptake
VO2peak (mL.kg-1.min-1) was assessed using breath-by-breath gas analyzer in an incremental test performed on a treadmill
Measured: Baseline, week 4 and week 8
Aerobic performance - change in Oxygen uptake
Maximal aerobic speed (km/h) was assessed in an incremental test performed on a treadmill
Measured: Baseline, week 4 and week 8
biochemical health markers - change in cortisol
Salivary cortisol was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
biochemical health markers - change in creatinine
plasma creatinine was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
biochemical health markers - change creatine kinase
plasma creatine kinase was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
biochemical health markers - change in glucose
plasma glucose was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
biochemical health markers - change in C reactive protein
plasma C Reactive Protein was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
biochemical health markers - change in Aspartate Aminotransferase
plasma Aspartate Aminotransferase was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
biochemical health markers - change in alanine aminotransferase
Plasma alanine aminotransferase was assessed using spectrophotometry techniques in an automated equipment.
Measured: Baseline, week 4 and week 8
Secondary outcomes (2)
Body composition parameter - change in phase angle
Phase angle (degree) was assessed by bioelectrical impedance analysis
Measured: Baseline, week 4 and week 8
Body composition parameter - change of visceral fat
Visceral fat (kg) was assessed by dual energy X-ray absorptiometry
Measured: Baseline, week 4 and week 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2022
- Study start1 Sep 2021
- Primary completion10 Dec 2021
- Study completion10 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Protein SupplementationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bettery S.A.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Principal investigator, Filipe Teixeira, Bettery S.A.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05228236
- Sponsor's protocol ID
- BetteryLifeLab4BP
- Acronym
- 4BettPro
- Status last verified
- Jan 2022
- First submitted
- 13 Jan 2022
- Last updated
- 8 Feb 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Feb 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparing the Effects of Plant Based Protein vs. Whey Protein on Performance and Body Composition of Futsal Players
- ClinicalTrials.gov ID
- NCT05228236
- Acronym / sponsor ID
- 4BettPro / BetteryLifeLab4BP
- Conditions
- Protein Supplementation
- Keywords
- Plant-based Protein, Body composition, Physical Performance, Biochemical Health Markers, Supplementation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Bettery S.A.Industry (pharma, biotech, devices)
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 10 Dec 2021 (actual)
- Study completion
- 10 Dec 2021 (actual)
- First posted
- 8 Feb 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to investigate the effects of a newly developed plant-based protein blend regarding health and safety, body composition, and performance on healthy and physically active adult individuals, specifically team sports athletes. A randomized, double-blind, controlled trial was used to compare the effects of the plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition, biochemical markers, muscle strength and power, as well as aerobic performance in male futsal players. The working hypothesis is that this special blend of plant-based protein will be equivalent to whey protein, not only regarding body composition and performance, but also insofar as health and safety at the biochemical and physiological level.
Detailed description
A randomized, double-blind, controlled trial was performed to investigate health and safety following supplementation with a newly developed plant-based protein blend and to compare the effects of this plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition and performance. Prior to intervention, volunteers' general health and ability to participate in the study were assessed. The study involved 50 male futsal players currently engaged in a training program and competing. Before engaging the 8-week supplementation protocol, participants underwent measurements of body composition, strength and power, and aerobic performance, as well as a full profile of biochemical health markers, and assessment of food and fluid intake. Evaluations were repeated after 4 weeks, for follow up and to detect potential compliance issues, and after 8 weeks of supplementation. Assessments took place in the morning (starting at 7:00 a.m.) after an overnight fast, except for the performance tests, which were performed following consumption of a standard, meal replacement bar.
Anthropometry and Body Composition - Wearing minimal clothing and no shoes, participants had their weight and height measured on a scale and stadiometer (Seca, Hamburg, Germany), respectively. Body composition, namely bone mineral content, fat mass and fat free mass, were evaluated by dual energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic, Waltham, USA) and skeletal muscle through the evaluation of the muscle thickness of the rectus femoris by ultrasonography (model WED-180 HL, Shenzhen,China). Total body water and its intra and extracellular compartments were estimated from whole body resistance (R) and reactance (Xc), measured through bioelectrical impedance analysis (BIA), using a single frequency device of 50 kHz (BIA-101, RJL/Akern Systems, Firenze, Italy). From the raw R and Xc data, the phase angle was additionally determined, using the Akern Software.
Muscle Strength and Power, and Aerobic Performance - Strength was assessed using the handgrip strength test, as well as the back squat and bench press 1 repetition maximum (1 RM). The handgrip strength test was used to evaluate the maximal isometric force of the muscles of the hand and forearm. Using a portable hand dynamometer (JAMAR, Sammons Preston, Bolingbrook, IL, USA), participants were assessed for both hands alternately, in a stand-up position. The maximal force generated out of 3 attempts was considered for analysis. Additionally, muscle strength was evaluated by 1RM back squat and bench press in a Multipower machine, using a velocity-based training device (Vitruve Encoder, Madrid, Spain). Muscle power was assessed during maximal cycling (Wingate test) and jumping movements. During the Wingate test, participants were instructed to cycle (Monark 894 Peak Bike, Vansbro, Sweden) against a predetermined resistance (7.5% body weight), as fast as possible, for 30 seconds. Vertical jumps, namely the squat jump, countermovement jumps using both legs and single legs, as well as the Abalakov countermovement jump, were performed on a multicomponent force platform (Chronojump Boscosystem, Barcelona, Spain) interfaced with a computer. The best out of 3 attempts was also considered for analysis of this methodology. Aerobic performance was assessed by VO2peak and maximal aerobic speed (MAS), determined using a breath-by-breath gas analyzer (Quark, Cosmed, Italy) in an incremental test performed on a treadmill (Axelero, MEDEN-INMED, Koszalin, Poland). After 3 minutes of warm-up at 5 km/h, participants began the test at 6 km/h and 2% inclination. Each minute, the speed increased 1 km/h until volitional exhaustion. The VO2peak was considered the highest 30 sec average value of VO2 and MAS, the speed at the last completed stage.
All tasks were performed by the participants with direct supervision of sport scientists and/or exercise physiologists, with prior knowledge of the methodologies, and experience handling the equipments and corresponding softwares.
Biochemical Markers - For biochemical health markers, saliva and whole blood, in EDTA tubes, were collected per the standard protocols. . From whole blood, plasma was separated when necessary. Blood measurements included hematocrit, glucose, C-reactive protein (CRP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), and creatinine, using spectrophotometry techniques in an automated equipment (Vario Photometer II DP310, Diglobal Gmbh, Berlin, Germany). Saliva was collected for cortisol evaluation in Enzyme-Linked Immunosorbent Assay (ELISA) commercial kits (Salimetrics, PA, USA).
Nutritional Assessment - Following extensive verbal and written instructions, diet control and food patterns were characterized using 3-day food records (2 non-consecutive weekdays and 1 weekend day). Participants were instructed to maintain their dietary pattern for the 8 weeks of the study. Energy, macronutrient, and micronutrient intake were quantified using a dietary analysis software (Nutritics Research Edition (v5.09), Dublin, Ireland).
Randomization and Supplementation - Eligible participants were assigned to one of the two arms of the study using a covariate adaptive randomization procedure considering the covariates age, handgrip strength, whole body fat-free mass, and whole-body fat mass percentage. The investigator responsible for the sample randomization and supplements distribution was not directly involved in participants' eligibility interview or data collection. The supplementation protocol was similar for both the plant-based and whey protein, with the uptake of a single dose of ~30 g occurring 30-60 min after physical practice on training days or 30-60 min before bedtime on rest days. Supplementation compliance was assessed by questionnaire at the end of weeks 4 and 8.
Sample Size Justification - Previous, similar studies showed no differences between the abovementioned supplements regarding the analyzed variables of interest. In cases where there are no differences between the arms of the study, an effect size does not exist, so a power analysis is not a valid approach. As our hypothesis is that there will be no difference between the newly developed plant-based protein blend and whey protein, we can consider a non-inferiority trial and, therefore, our sample size can be similar to that of previous studies. Additionally, despite the time course of muscle hypertrophy not being exactly known, an 8-week intervention would be considered the minimum timeline for true hypertrophy to be detectable/measurable after 6-8 weeks of resistance training (using medical imageology i.e., ultrasound). Furthermore, it has been reported that to detect hypertrophy differences following supplementation with proteins of different quality, the number of subjects needed should be in the range of at least 25 per group. We have chosen to go with a robust approach. Therefore, our proposed sample size is of 25 participants per group.
Statistics - All statistical analyses are being carried out using IBM SPSS Statistics (Version 25.0, NY, IBM). Basic descriptive data were run to characterize the study participants. All variables were checked for normality, using Kolmogorov-Smirnov test. Participants were assigned to either a plant-based protein (n = 25) or animal protein group (n = 25), based on handgrip strength, age, fat mass or fat-free mass using a stratified random assignment. Independent Sample T tests will be applied to compare means between supplementation groups, at baseline. Time and time-by-group interactions will be evaluated by repeated-measures ANOVA. The equality of the matrix of variance and sphericity will be explored with the Levene F test and Mauchly's test, respectively. Overall significance level for α will be set at p ≤ 0.05.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Plant based protein | Experimental | Dietary Supplement: Plant based protein |
| Whey Protein | Experimental | Dietary Supplement: Whey protein |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Subjects currently engaged in a Futsal training program in a competition team, currently engaged in practice for at least 1 year and at least 3 times per week.
Key exclusion criteria (2 listed)
- Individuals taking any type of drug (including anabolic steroids), medicines or supplements that may enhance body composition or performance, 3 months prior to the beginning of the trial.
- Clinical diagnose of a disease that might compromise tolerance to the supplements or influence body composition or performance.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Plant based proteinA single dose of ~30 g of a plant-based protein blend was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days. | Dietary supplement | Plant based protein |
| Whey proteinA single dose of ~30 g of whey protein was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days. | Dietary supplement | Whey Protein |
Primary outcome
Body composition parameter - change in fat free mass (FFM)
Time frame: Baseline, week 4 and week 8
FFM (kg) was assessed by dual energy X-ray absorptiometry
Body composition parameter - change in fat mass (FM)
Time frame: Baseline, week 4 and week 8
FM (%) was assessed by dual energy X-ray absorptiometry
Body composition parameter - change in muscle thickness
Time frame: Baseline, week 4 and week 8
muscle thickness of the rectus femoris (mm) was assessed by ultrasonography
Body composition parameter - change in body water
Time frame: Baseline, week 4 and week 8
total body water, intracellular water and extracellular water (L) were assessed by bioelectrical impedance analysis
Performance parameter - change in strength
Time frame: Baseline, week 4 and week 8
Maximal isometric forearm strength (N) was assessed using a handgrip dynamometer
Performance parameter - change in maximum strength
Time frame: Baseline, week 4 and week 8
Maximum strength (kg) was predicted from 1-RM in back squat and bench press exercises using a Multipower machine withVitruve technology
Performance parameter - change in peak power
Time frame: Baseline, week 4 and week 8
Muscle power (Watt) was assessed with a supramaximal cycling test on cycle ergometer
Performance parameter - change in jump height
Time frame: Baseline, week 4 and week 8
Vertical jump height (cm) was assessed on a multicomponent force platform interfaced with the Chronojump software
Aerobic performance - change in Oxygen uptake
Time frame: Baseline, week 4 and week 8
VO2peak (mL.kg-1.min-1) was assessed using breath-by-breath gas analyzer in an incremental test performed on a treadmill
Aerobic performance - change in Oxygen uptake
Time frame: Baseline, week 4 and week 8
Maximal aerobic speed (km/h) was assessed in an incremental test performed on a treadmill
biochemical health markers - change in cortisol
Time frame: Baseline, week 4 and week 8
Salivary cortisol was assessed using spectrophotometry techniques in an automated equipment.
biochemical health markers - change in creatinine
Time frame: Baseline, week 4 and week 8
plasma creatinine was assessed using spectrophotometry techniques in an automated equipment.
biochemical health markers - change creatine kinase
Time frame: Baseline, week 4 and week 8
plasma creatine kinase was assessed using spectrophotometry techniques in an automated equipment.
biochemical health markers - change in glucose
Time frame: Baseline, week 4 and week 8
plasma glucose was assessed using spectrophotometry techniques in an automated equipment.
biochemical health markers - change in C reactive protein
Time frame: Baseline, week 4 and week 8
plasma C Reactive Protein was assessed using spectrophotometry techniques in an automated equipment.
biochemical health markers - change in Aspartate Aminotransferase
Time frame: Baseline, week 4 and week 8
plasma Aspartate Aminotransferase was assessed using spectrophotometry techniques in an automated equipment.
biochemical health markers - change in alanine aminotransferase
Time frame: Baseline, week 4 and week 8
Plasma alanine aminotransferase was assessed using spectrophotometry techniques in an automated equipment.
2 secondary outcomes
Body composition parameter - change in phase angle
Time frame: Baseline, week 4 and week 8
Body composition parameter - change of visceral fat
Time frame: Baseline, week 4 and week 8
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Feb 2022.
- Individual participant dataSharing planned: No
Related trials for Protein Supplementation
Recruiting
PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy
Gynecologic Cancer
Recruiting
Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
Obesity & Overweight, Muscle Mass and Strength
Recruiting
Fueling Labor: Protein Supplementation for Intrapartum Glucose Control
Diabetes During Pregnancy
Recruiting
IgG Binding Protein LT in Support of a Healthy Gut on the Go
Gut Health, Gastrointestinal Symptoms
Recruiting
Alpha-Lipoic Acid as an Adjunct to Non-Surgical Periodontal Treatment in Gingivitis
Gingivitis and Periodontal Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Plant based protein and Whey protein in people with Protein Supplementation, run by Bettery S.A. at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body composition parameter - change in fat free mass (FFM) (time frame: Baseline, week 4 and week 8). The study lists 17 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2022.